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Abstract

Temporal and spatial patterns of pathological changes such as loss of neurons and presence of pathological
protein aggregates are characteristic of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis,
Frontotemporal Dementia, Alzheimer's disease and Parkinson's disease. These patterns are consistent with the
propagation of protein misfolding and aggregation reminiscent of the prion diseases. There is a surge of
evidence that suggests that large protein aggregates of a range of proteins are able to enter cells via
macropinocytosis. Our recent work suggests that this process is activated by the binding of aggregates to the
neuron cell surface. The current review considers the potential role of cell surface receptors in the triggering of
macropinocytosis by protein aggregates and the possibility of utilizing macropinocytosis pathways as a
therapeutic target.
Disciplines

Medicine and Health Sciences | Social and Behavioral Sciences
Publication Details

Yerbury, J. J. (2016). Protein aggregates stimulate macropinocytosis facilitating their propagation. Prion, 10
(2), 119-126.

This journal article is available at Research Online: http://ro.uow.edu.au/smhpapers/3883

Extra View

Protein aggregates stimulate macropinocytosis facilitating their propagation.
Justin J. Yerbury

Proteostasis and Disease Research Centre, School of Biological Sciences, Faculty of
Science, Medicine and Health, University of Wollongong, Wollongong, Australia
2522.
and

Downloaded by [University of Wollongong] at 15:27 05 April 2016

Illawarra Health and Medical Research Institute, Wollongong, Australia 2522

To whom correspondence should be addressed; jyerbury@uow.edu.au
Original Article:
Zeineddine, R., J. F. Pundavela, L. Corcoran, E. M. Stewart, D. Do-Ha, M. Bax, G.
Guillemin, K. L. Vine, D. M. Hatters, H. Ecroyd, C. M. Dobson, B. J. Turner, L. Ooi,
M. R. Wilson, N. R. Cashman and J. J. Yerbury (2015). "SOD1 protein aggregates
stimulate macropinocytosis in neurons to facilitate their propagation." Mol
Neurodegener 10(1): 57. http://dx.doi.org/10.1186/s13024-015-0053-4
Abstract
Temporal and spatial patterns of pathological changes such as loss of neurons and
presence of pathological protein aggregates are characteristic of neurodegenerative
diseases such as Amyotrophic Lateral Sclerosis, Frontotemporal Dementia,
Alzheimer’s disease and Parkinson’s disease. These patterns are consistent with the
propagation of protein misfolding and aggregation reminiscent of the prion diseases.
There is a surge of evidence that suggests that large protein aggregates of a range of
proteins are able to enter cells via macropinocytosis. Our recent work suggests that
this process is activated by the binding of aggregates to the neuron cell surface. The
current review considers the potential role of cell surface receptors in the triggering of
macropinocytosis

by

protein

aggregates

and

the

possibility

of

utilizing

macropinocytosis pathways as a therapeutic target.
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Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS),
Frontotemporal Dementia (FTD), Alzheimer’s disease, and Parkinson’s disease have
temporal and spatial patterns of pathological changes such as loss of neurons and
presence of pathological protein aggregates1-4. The patterns that have been identified
in neuropathological studies are have been suggested to be consistent with
propagation of protein misfolding and aggregation reminiscent of the prion diseases5.

Evidence from in vitro studies suggests that large protein aggregates of a range of
proteins (SOD1, tau, α-synuclein, and proteins containing expanded polyglutamine
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repeats) are able to enter cells via an incompletely understood mechanism and
propagate misfolding and aggregation6-14. Animal studies demonstrate that injection
of brain or spinal cord extracts from transgenic mice expressing human tau, SOD1 or
α-synuclein can seed pathology in transgenic mice at the sites of injection and initiate
spread of pathology to other regions of the nervous system14-17. These data combined
with the patterns of neurodegeneration provide strong evidence of prion-like protein
misfolding propagation in neurodegenerative diseases such as Parkinson’s disease and
ALS. The precise mechanism of cell-to-cell propagation of protein misfolding in vivo
remains unclear. There are several possible scenarios that may explain the
propagation of protein misfolding, the most commonly proposed of which is the
release of protein aggregates in to the extracellular space and subsequent uptake in to
nearby or connected naïve neurons where seeding can then take place. In this model
both aggregate release and subsequent uptake are requisite. Misfolded or aggregated
material may be released from cells via an active mechanism, either within exosomes
or naked, or alternatively, aggregates may be passively released from dead or dying
cells. In reality, within a complex biological system it is likely that the release of
aggregated protein may be a combination of each of the possible release mechanisms.
This makes therapeutic targeting of aggregate release difficult, moreover, reducing
the burden of misfolded protein by active release may be beneficial to the cell and
thus its blockade detrimental. One aspect of protein misfolding propagation that may
provide a more tractable therapeutic target is the entry of protein aggregates in to
cells.

Work to date suggests that macropinocytosis may be responsible for the uptake of
protein aggregates associated with various neurodegenerative diseases6,

11, 18-21

. A
2

range of studies examining several different types of protein aggregates, including
those made from α-synuclein, Huntingtin (exon1Q44), and tau are consistent with an
unconventional, bulk endocytosis route being responsible for their uptake12, 18, 22-25. A
systematic study using SOD1 aggregates by Münch et. al conlcuded that protein
aggregates enter into N2A cells via macropinocytosis19. These findings were
subsequently corroborated in work that showed uptake of both extracellular wildtype
and mutant SOD1 soluble forms into NSC-34 cells can be inhibited by small molecule
inhibitors of macropinocytosis EIPA and rottlerin11,

20

. EIPA (5-(N-Ethyl-N-

isopropyl)amiloride) is an amiloride analogue that inhibits Na+/H+ exchangers which
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suppresses macropinocytosis due to the vulnerability of GTPase Rac1 to pH
changes26. However, the small molecule inhibitors generally utilized to define
macropinocytosis, such as EIPA, are not specific and have been shown to prevent
various forms of endocytosis27. As a result, further work is required to more precisely
define the precise mode of endocytosis responsible for protein aggregate uptake.

Macropinocytosis is a type of endocytosis that is partly defined by pinosome size,
macropinosomes can be several micron in diameter. Macropinocytosis can be
constitutive or a transient process, generally triggered by growth factors but has been
observed to be activated by particles such as bacteria, apoptotic bodies and viruses28.
Its activation leads to formation of large membrane ruffles that can fold back on the
cell allowing the internalisation of fluid, membrane and other particles into large
vacuoles several micron in diameter29. The role of stimulation of macropinocytosis in
aggregate uptake remains unclear.

Our recent work shows that SOD1 aggregates can bind to the cell surface and trigger
activation of membrane ruffling in NSC-34 cells and iPSC generated human neurons
21

consistent with stimulated rather than constitutive macropinocytosis. The

engulfment of aggregates in to macropinosomes could explain the ease by which
aggregates enter the cytosol. Macropinosomes are considered ‘leaky’ due to their lack
of physical structure compared with coated vesicles30. Indeed, we observed vesicle
rupture upon entry of SOD1 aggregates in to NSC-34 cells21.

A characteristic

signaling molecule associated with actin mobilization during macropinocytosis in the
Rho GTPase Rac1. We found that application of SOD1 aggregates to NSC-34 cells
resulted in an increase in the amount of activated Rac1, and also observed that the
3

uptake of aggregated SOD1 in to NSC-34 and human iPSC derived motor neurons
was suppressed by the Rac1 inhibitor W5621.

These data are consistent with a

triggering of macropinocytosis that involves an activation of Rac1. Moreover, our
data indicate that aggregates made from other proteins such as α-synuclein,
huntingtin-polyQ and TDP-43 also trigger membrane ruffling and macropinocytosis21.
Indeed, this seems to be a generic response to cell surface interaction with protein
aggregates since aggregates made from α-lactalbumin, that are not involved with
disease, also trigger this response.
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The question of how protein aggregates trigger macropinocytosis remains
unanswered. To begin to shed light on the answer to this question one can turn to the
virus uptake literature as the mechanisms of macropinocytosis activation have been
more closely studied in this context. There are a several viruses28 that have been
shown to utilise macropinocytosis pathways to enter cells, including the Japanese
encephalitis virus in neurons31. Receptor complexes on the cell surface are vital to the
binding of viral particles and activation of macropinocytosis. Integrins such as β132,
αv33, and the heparan sulfate proteoglycans34 have been reported to be involved in
particle binding, while receptor tyrosine kinases such as ErbB-135 and EphA236 have
been implicated in the triggering of the signalling cascade that stimulates
macropinocytosis (Figure 1A). Little is known about the receptors that mediate
protein aggregate induced macropinocytosis in neurons. However, heparan sulfate
proteoglycans have been identified as an important part of the mechanism that allows
tau, α-synuclein and prion protein aggregate uptake18, 37, 38 suggesting that the receptor
complexes involved may be similar to that involved in virus particle uptake.

While little is known about the neuronal receptor complexes associated with binding
of protein aggregates, a wide range of receptors have been shown to be involved in
the binding of protein aggregates to the cell surface of microglia39, 40. A group of
receptors, known as pattern recognition receptors, are often responsible for this
process. These receptors bind to pathogen-associated molecular patterns (PAMPs)
and danger associated molecular patterns (DAMPs) that may be responsible for the
recognition of protein aggregates. It is possible that these pattern recognition
receptors bind to the repetitive patterns found on aggregates formed from various
proteins, indeed the fibrillar structure of amyloid fibrils are thought to have a generic
4

core structure. The binding of particles to these microglial receptor complexes results
in activation of signalling cascades, including activation of MAP kinase and ERK1/2,
subsequently resulting in cytokine release41. Scavenger receptors CD3642 and SR-A43,
the receptor for advanced glycation end products (RAGE)44, 45, integrin α6β1-integrin
and integrin associated CD4740, formyl peptide receptor 2/ formyl peptide receptorlike 1 (FPR2/FPRL1)46, CD3347, CD14 and Toll-like receptors (TLR) 2/448 have all
been shown to be involved in microglial binding of protein aggregates made of Aβ
peptide. In addition, we have previously shown that microglia binding of aggregated
SOD1 is supressed by pre-treatment with methyl-β-cyclodextrin (MβCD), fucoidan
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and lipopolysaccharide (LPS) suggesting that binding is dependent on lipid raft
formation, scavenger receptors and CD1449. The binding of fibrils to microglial cell
surface is mediated not by individual receptors but though large receptor complexes
(Figure 1B) involving signalling receptors such as TLR2/4. This process of receptor
complex formation, in some cases, is dependent on lipid raft formation to allow
membrane protein organization50.
Neurons express heparan sulfate proteoglycans51, RAGE52, CD3653, integrins33 and
receptor tyrosine kinases such as EphA2 and EphA454. This is consistent with neurons
having all the machinery to bind aggregates and to trigger macropinocytosis with a
receptor complex similar to that involved in viral uptake and somewhat similar to that
of microglial cell surface recognition (Figure 1C). Indeed, a macropinocytosis-like
process regulates growth cone membrane recycling, growth cone collapse, axon
retraction and turning during development and injury55-59. Future work will be needed
to further characterise the composition of the neuron specific set of cell surface
proteins that are responsible for the binding, triggering of macropinocytosis and
uptake of protein aggregates. Given that blocking all macropinocytosis in the brain,
including microglial and astrocytic, may be detrimental this knowledge could be used
to define a specific target to block neuronal uptake of protein aggregates. Blocking
uptake may effectively supress propagation of protein aggregation, as the cytoplasmic
invasion of protein aggregates, like those of SOD1, are a necessary part of the prionlike propagation process. However, due to the role of a macropinocytic process in
growth cone and axon development55-59 the effect of inhibition of macropinocytosis
on neurogenesis should be studied. Regardless, a receptor tyrosine kinase EphA4 has
been implicated in ALS disease progression. In humans with ALS, EphA4 expression
5

was found to inversely correlate with disease onset and survival, and loss-of-function
mutations in EPHA4 were found to be associated with slower disease progression and
longer survival60. It is tempting to speculate that EphA4 might contribute to the
activation of macropinocytosis and uptake of protein aggregates, which might be
slowed in its absence or inhibition. Identifying such a target that will supress the
neuronal macropinocytosis of protein aggregates but will allow the microglial
phagocytosis and degradation of such particles is vital. Blocking all endocytosis of
aggregates may be detrimental.
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In summary, propagation of protein misfolding and aggregation is implicated in the
progressive nature of several neurodegenerative diseases such as Alzheimer’s disease,
Parkinson’s disease and ALS. In order for propagation to proceed aggregates must be
able to gain access to the cytosol of naïve neurons and current evidence suggests that
stimulated macropinocytosis is responsible for this uptake. The receptor complexes
responsible for this are still to be defined, but this information may provide
therapeutic targets that could halt or slow the spread of pathology.
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Figure 1. Cell surface receptors responsible for macropinocytosis and protein
aggregate recognition. A) Receptor tyrosine kinases (RTK), integrins (INT) and
heparan sulfate proteoglycans (HS) have been associated with the viral particle
recognition and subsequent triggering of macropinocytosis. B) Scavenger receptors
(SR), RAGE, integrins (INT), CD14 and toll like receptors (TLR) have all been found
to play a role in recognition and subsequent proinflammatory response to protein
aggregates of amyloid β peptide. C) Neurons have been shown to express scavenger
receptors (SR), receptor tyrosine kinases (RTK), integrins (INT) and heparan sulfate
proteoglycans which may be involved in triggering of macropinocytosis by protein
aggregates.
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